Notices to Members

September 15, 2020

Coronavirus (COVID-19) Update—Extension to Certain Regulatory Relief for FCMs, RFEDs, IBs and SDs

The CFTC recently issued no-action letter 20-26 extending through January 15, 2021, certain no-action relief issued in response to the COVID-19 pandemic. The relief, previously set to expire on September 30, 2020, applies exclusively to certain regulatory obligations of FCMs, RFEDs (i.e., FDMs), IBs and SDs. NFA is also extending through January 15, 2021 similar relief for Members that are in compliance with the terms of the CFTC's no-action relief. Specific relief subject to this extension is detailed in NFA's Notice to Members I-20-13.

If you have any questions on this Notice, please contact Valerie O'Malley, Director, Futures Compliance (vomalley@nfa.futures.org or 312-781-1290) or Joe Zangri, Managing Director, OTC Derivatives (jzangri@nfa.futures.org or 212-346-5632).

Timely information and guidance for Members and the investing public continues to be posted to NFA's dedicated COVID-19 webpage as it becomes available.